Device developer Merxin has announced the availability of its MRX001 “off the shelf” multidose dry powder inhaler.
According to an announcement on the website of Merxin sister company Aedestra, the blister-based DPI is designed for developers of generic combination products planning to submit a 505(j) application.
Read the Aedestra announcement.
published on
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
